The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs
Eleonora Nardini, Ernesto Rodríguez, Yvette van Kooyk
Abstract
The immune system is a complex network of highly specialized microenvironments, denominated niches, which arise from dynamic interactions between immune and parenchymal cells as well as acellular components such as structural elements and local molecular signals. A critical, yet underexplored, layer shaping these niches is the glycome, the complete repertoire of glycans and glycoconjugates produced by cells. The glycome is prevalent in the outer membrane of cells and their secreted components, and can be sensed by glycan binding receptors on immune cells. These receptors detect changes in glycosylation and consequently modulate immune cell activity, trafficking, and signalling, altering homeostasis. Tissues like the brain and the placenta are prone to accommodate tolerance, while the gut and the thymus are sensitive to inflammation. We provide here an overview of current literature that shows the impact of altered glycosylation of tissues on host immune cells and how interference in this process may lead to new diagnostics and immune therapeutics, aiming to restore the immune balance in autoimmunity and cancer. • Glycans in tissues modulate immune cell activity via glycan binding proteins. • The tissue-glycome contributes to maintaining tolerance or promoting inflammation. • Altered tissue glycosylation impacts immune cell function and homeostasis. • Targeting glycans or GBPs may lead to new diagnostics and immune therapeutics.